Anna Holst Fyhn
University of Southern Denmark
Tlf.: +45 30 89 44 30/ +45 60 50 22 58
University of Copenhagen, Faculty of Law, CeBIL, Center for Advanced Studies in Biomedical Innovation Law
Tel.: +45 35 33 39 07
Starting date: 1 September 2017
Completion date: 31 August 2020
An investigation of the triangular dilemma of strong Intellectual Property protection, contra high prices of medicines as result of the global Intellectual Property regime and finally the legal-economic rationales and discourses underlying Intellectual Property Law / competition law / intervention. The aim is to establish what constitutes anti-competitive practices such as excessive prices in TRIPS & EU Competition Law, by making the case for the excessiveness of prices as an anti-competitive practice in and out of themselves from a legal-economic / competition law perspective.